Diabetes treatment is constantly evolving, with new therapeutic options developing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions https://saulshek901829.fitnell.com/79865006/promising-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment